Trial intelligence / Profile preview

Melatonin in Elevated Blood Pressure

IRCT20181003041218N2Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin in hypertension (HTN), sponsored by Tehran University of Medical Sciences. Started Dec 2018; status: completed.

02

Drugs

melatonin
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on IRCT20181003041218N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181003041218N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call